- Home
- CTNT vs AIDX Comparison
CTNT vs AIDX Comparison
Compare CTNT & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNT | AIDX |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 2.9M |
| IPO Year | 2023 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CTNT | AIDX |
|---|---|---|
| Price | $1.60 | $0.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 92.5K | ★ 187.3K |
| Earning Date | 11-17-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.74 | 34.48 |
| EPS | ★ N/A | N/A |
| Revenue | $1,288,536.00 | ★ $2,045,133.00 |
| Revenue This Year | $78.50 | $44.20 |
| Revenue Next Year | $52.17 | $95.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 182.69 | 16.71 |
| 52 Week Low | $0.03 | $0.21 |
| 52 Week High | $2,120.00 | $18.96 |
Technical Indicators
Market Signals| Indicator | CTNT | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 30.24 |
| Support Level | $0.04 | N/A |
| Resistance Level | $3.92 | $0.69 |
| Average True Range (ATR) | 0.18 | 0.02 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 6.14 | 21.02 |
Price Performance
Historical ComparisonAbout CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.